title: Higher incidence of peritonitis in native Canadians on continuous ambulatory peritoneal dialysis.
abstract: OBJECTIVE
  To determine if the rate of peritoneal dialysis (PD)-related infections in our large Native population was higher than in non-Natives.
  
  
  METHODS
  Prospective study of PD-related infections, 1987 to 1993.
  
  
  METHODS
  Forty-eight Natives and 136 non-Natives were studied. Comparisons of infection rates were made as well as determinations of the effect of diabetes and of dialysis techniques on infection rate.
  
  
  RESULTS
  The chance of remaining free of peritonitis was far lower at 6 and 12 months in Natives versus non-Natives, 40% versus 76% at 6 months, and 24% versus 54% at 12 months (p < 0.01). Having diabetes or adding intraperitoneal insulin did not confer additional risk of peritonitis. The Y-line reduced the risk of peritonitis in non-Natives only. Exit-site infection (ESI) was significantly higher in Natives versus non-Natives, 0.42 versus 0.19 episodes per patient year (p < 0.01) mainly due to Staph. aureus. However, less than 30% of episodes of peritonitis were due to that organism. Staph. epidermidis peritonitis episodes were not more common in Native patients, whereas infections due to most other organisms were.
  
  
  CONCLUSIONS
  The susceptibility to both peritonitis and exit-site infection is increased in Native Canadians compared to non-Natives. The nonprotective effect of the Y-line combined with increased peritonitis due to most organisms except Staph. epidermidis in Natives suggests that host factors could be important in these patients.
authors.affiliation: Section of Nephrology, St. Boniface Hospital, Winnipeg, Manitoba, Canada.
authors.forename: A
authors.initials: A
authors.lastname: Fine
authors.forename: D
authors.initials: D
authors.lastname: Cox
authors.forename: M
authors.initials: M
authors.lastname: Bouw
mesh_terms: D000328:Adult; D001424:Bacterial Infections / Q000453:epidemiology / Q000208:ethnology; D002170:Canada / Q000453:epidemiology; D003928:Diabetic Nephropathies / Q000628:therapy; D005260:Female; D006801:Humans; D007198:Indians, North American; D004930:Inuit; D007676:Kidney Failure, Chronic / Q000628:therapy; D008297:Male; D008875:Middle Aged; D010531:Peritoneal Dialysis, Continuous Ambulatory / Q000009:adverse effects*; D010538:Peritonitis / Q000453:epidemiology / Q000208:ethnology / Q000209:etiology*; D011446:Prospective Studies; D012307:Risk Factors